Philip Morris International (PM) is back in focus after Q4 results that met revenue expectations but fell short on some profit measures, as the board reaffirmed a regular quarterly dividend of $1.47 per share.

At a share price of $169.98, Philip Morris International has seen a 90 day share price return of 15.00% and a 1 year total shareholder return of 16.59%. Shorter term price weakness after earnings and institutional selling hints that momentum has cooled recently compared with its strong 3 and 5 year total shareholder returns.

If this update has you thinking more broadly about income and defensiveness, it could be a good moment to widen your search with our 20 top founder-led companies.

With revenue and earnings expectations already in the spotlight, a US$1.47 quarterly dividend reaffirmed, and analysts’ targets sitting above the current US$169.98 share price, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 5.8% Undervalued

Philip Morris International’s most followed narrative points to a fair value of $180.38 compared with the current $169.98 share price, with the story built around measured growth, high margins and a relatively modest discount rate of 7.72%.

The accelerating global adoption of smoke free alternatives driven by increasing health awareness and regulatory moves away from combustibles is fueling strong double digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.

Curious what kind of revenue build, margin profile and future P/E need to line up to reach that fair value number? The narrative leans on steady top line expansion, meaningfully higher profitability and a rerating that still sits under some sector multiples. The full set of assumptions connects these threads into one valuation story.

Result: Fair Value of $180.38 (UNDERVALUED)

However, you still need to weigh regulatory and tax risks on nicotine products, as well as the possibility that smoke free growth slows, which could challenge this valuation story.

Another Way To Look At Value

So far, the story has leaned on a fair value of $180.38 that suggests a modest discount. If you step back and just look at the current P/E of 23.4x though, the picture feels tighter. It is above the global tobacco average of 13.5x, roughly in line with peers at 24.5x, yet still below a fair ratio of 27.1x on Simply Wall St’s work, which suggests the market could move higher or stay put. Is that a margin of safety you are comfortable with, or is the risk that expectations slip weighing more on your mind?

Next Steps

If the mix of positives and concerns feels finely balanced here, do not wait around. Review the details for yourself and weigh 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

Before you move on, give yourself an edge by lining up a few more candidates that could complement or contrast what you have just seen here.

• Target steady income by checking out 16 dividend fortresses, built for investors who want yield with support from underlying fundamentals.
• Hunt for potential bargains using our 50 high quality undervalued stocks, where the focus is on quality businesses trading below their assessed worth.
• Prioritise resilience with the 63 resilient stocks with low risk scores, highlighting companies that score well on financial strength and overall risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.